Xuanbo Zhang
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery 21
- Biomedical Engineering top 2%
- Nanoplatforms for cancer theranostics 28
- Pharmaceutical Science top 5%
- Immunology top 10%
- Molecular Biology top 10%
- Extracellular vesicles in disease 7
- RNA Interference and Gene Delivery 6
-
- Photodynamic Therapy Research Studies 9
-
- Advanced Nanomaterials in Catalysis 5
-
- Geochemistry and Elemental Analysis 4
-
- Aluminum toxicity and tolerance in plants and animals 4
- Journals
- Chemical Society Reviews (1 paper)Angewandte Chemie International Edition (1 paper)Nature Communications (4 papers)
- Partner nations
- ChinaSingaporeUnited Kingdom
In The Last Decade
Xuanbo Zhang
48 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 105
- Biomaterials 1.0k
- Biomedical Engineering 1.6k
- Pharmaceutical Science 92
- Immunology 318
- Molecular Biology 1.0k
Countries citing papers authored by Xuanbo Zhang
This map shows the geographic impact of Xuanbo Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuanbo Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuanbo Zhang more than expected).
Fields of papers citing papers by Xuanbo Zhang
This network shows the impact of papers produced by Xuanbo Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuanbo Zhang. The network helps show where Xuanbo Zhang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xuanbo Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 4 | |
| 3 | 2024 | 17 | |
| 4 | 2023 | 42 | |
| 5 | Gas therapy potentiates aggregation-induced emission luminogen-based photoimmunotherapy of poorly immunogenic tumors through cGAS-STING pathway activationbreakdown → | 2023 | 189 |
| 6 | 2023 | 67 | |
| 7 | 2023 | 20 | |
| 8 | 2023 | 52 | |
| 9 | 2023 | 28 | |
| 10 | 2023 | 39 | |
| 11 | 2023 | 7 | |
| 12 | 2021 | 42 | |
| 13 | 2021 | 43 | |
| 14 | 2021 | 62 | |
| 15 | 2019 | 11 | |
| 16 | 2019 | 29 | |
| 17 | Disulfide Bond-Driven Oxidation- and Reduction-Responsive Prodrug Nanoassemblies for Cancer Therapybreakdown → | 2018 | 370 |
| 18 | 2018 | 21 | |
| 19 | 2015 | 23 | |
| 20 | 2014 | 7 |
About Xuanbo Zhang
Xuanbo Zhang is a scholar working on Biomaterials, Geochemistry and Petrology and Biomedical Engineering, having authored 49 papers that have together received 2.5k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (28 papers), Nanoparticle-Based Drug Delivery (21 papers), Photodynamic Therapy Research Studies (9 papers), Extracellular vesicles in disease (7 papers), RNA Interference and Gene Delivery (6 papers), Advanced Nanomaterials in Catalysis (5 papers), Geochemistry and Elemental Analysis (4 papers) and Aluminum toxicity and tolerance in plants and animals (4 papers). The work is most often cited by research in Biomaterials (1.0k citations), Biomedical Engineering (1.6k citations) and Pharmaceutical Science (92 citations). Xuanbo Zhang has collaborated with scholars based in China, Singapore and United Kingdom. Frequent co-authors include Zhonggui He, Jin Sun, Cong Luo, Bingjun Sun, Qiming Kan, Haotian Zhang, Yu Han, Qin Chen, Shenwu Zhang and Menglin Wang. Their work appears in journals such as Chemical Society Reviews, Angewandte Chemie International Edition and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.